Results 131 to 140 of about 344,744 (207)

Characteristics of Mucosa-Associated Microbiota in Ulcerative Colitis Patients with 5-Aminosalicylic Acid Intolerance. [PDF]

Biomedicines
Matsumoto H, Sasahira M, Go TT, Yo S, Ninomiya T, Osawa M, Handa O, Umegami E, Inoue R, Shiotani A.   +9 more
europepmc   +1 more source

Risk factors for non-responsiveness to 5-aminosalicylic acid in patients with ulcerative colitis identified using retrospective clinical study and Mendelian randomization. [PDF]

Sci Rep
Ye ZN, Liu XT, Gu YM, Mao SX, Liang DH, Zhan K, Lei HQ, Huang SG.   +7 more
europepmc   +1 more source

Efficacy of Dose Escalation of Oral 5-Aminosalicylic Acid for Ulcerative Colitis With a Mayo Endoscopic Subscore of 1: An Open Label Randomized Controlled Trial. [PDF]

Inflamm Bowel Dis
Fukuda T, Aoki Y, Kiyohara H, Yokoyama A, Nakazawa A, Yoshimatsu Y, Sugimoto S, Nanki K, Mikami Y, Fukuhara K, Mizuno S, Sujino T, Mutaguchi M, Takabayashi K, Morohoshi Y, Hosoda Y, Ogata H, Iwao Y, Naganuma M, Kanai T.   +19 more
europepmc   +1 more source

Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitis. [PDF]

Cochrane Database Syst Rev, 2020
Murray A, Nguyen TM, Parker CE, Feagan BG, MacDonald JK.   +4 more
europepmc   +1 more source

Successful Treatment of Refractory Ulcerative Colitis With 5-Aminosalicylic Acid Intolerance and Biologic Therapy Resistance Using Combined Granulocyte and Monocyte Adsorptive Apheresis. [PDF]

Cureus
Tanaka T, Hirano D, Ishimaru S, Arataki K.   +3 more
europepmc   +1 more source

Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis. [PDF]

Cochrane Database Syst Rev, 2020
Murray A, Nguyen TM, Parker CE, Feagan BG, MacDonald JK.   +4 more
europepmc   +1 more source

Simultaneous Treatment of 5-Aminosalicylic Acid and Treadmill Exercise More Effectively Improves Ulcerative Colitis in Mice. [PDF]

Int J Mol Sci
Jin JJ, Ko IG, Hwang L, Kim SH, Jee YS, Jeon H, Park SB, Jeon JW.   +7 more
europepmc   +1 more source

Investigating the effects of vitamin D3 and 5-aminosalicylic acid (Mesalazine) on the expression of virulence determinants in <i>Escherichia coli</i> isolated from patients with IBD and colorectal cancer. [PDF]

Gastroenterol Hepatol Bed Bench
Abolfazl Hosseininasab S, Saffari F, Tadjrobehkar O, Zandi H, Ahmadi B.   +4 more
europepmc   +1 more source

5-Aminosalicylic Acid-Induced Liver Injury in a Patient with Ulcerative Colitis: A Case Report. [PDF]

Case Rep Gastroenterol
Watanabe A, Nishida T, Osugi N, Kitanaka T, Minoura Y, Okabe S, Sakamoto N, Fujii Y, Sugimoto A, Nakamatsu D, Matsumoto K, Yamamoto M, Adachi S, Fukui K.   +13 more
europepmc   +1 more source

Sustained release of 5-aminosalicylic acid from azoreductase-responsive polymeric prodrugs for prolonged colon-targeted colitis therapy. [PDF]

J Nanobiotechnology
Tang S, Wang W, Wang Y, Gao Y, Dai K, Zhang W, Wu X, Yuan X, Jin C, Zan X, Zhu L, Geng W.   +11 more
europepmc   +1 more source